Study on Determine the Utilisation and Clinical Outcomes of Evusheld in COVID-19 PrEP in China
Clinical trial NCT05917951 · COMPLETED
Trial details
- NCT number
- NCT05917951
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-24
- Primary completion
- 2023-07-20
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.